Mitocryptide-2, a neutrophil-activating cryptide, is a specific endogenous agonist for formyl-peptide receptor-like 1

被引:22
|
作者
Seki, Tetsuo [2 ]
Fukamizu, Akiyoshi [2 ]
Kiso, Yoshiaki [1 ]
Mukai, Hidehito [1 ]
机构
[1] Kyoto Pharmaceut Univ, Ctr Frontier Res Med Sci, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan
[2] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan
关键词
Cryptide; Mitocryptide; Neutrophil-activating peptide; Formyl-peptide receptor; FPR; FPRL1; PROTEIN-COUPLED RECEPTOR; MAST-CELLS; IDENTIFICATION; MECHANISMS; BINDING; 7-TRANSMEMBRANE; EXPRESSION; MASTOPARAN; INJURY; TISSUE;
D O I
10.1016/j.bbrc.2010.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptides simultaneously produced during maturation and degradation of peptidergic hormones and functional proteins have recently become a great interest because they display unpredictably different biological roles than the parent proteins. Namely, we discovered two novel functional cryptic peptides, mitocryptide-1 (MCT-1) and mitocryptide-2 (MCT-2), hidden in mitochondrial cytochrome c oxidase and cytochrome b, that efficiently induced neutrophilic migration and activation at nanomolar concentrations. We named these functional "cryptic" peptides hidden in protein structures as "cryptides." In this study, we investigated the receptor molecules and cellular signaling mechanisms for neutrophil-activating N-formylated cryptide MCT-2. In order to identify the receptor molecules, we established HEK-293 cells stably expressing either formyl-peptide receptor (FPR) or its homologue FPR-like 1 (FPRL1), because neutrophilic cells express these receptor molecules which recognize N-formylated peptides. We observed that MCT-2 directly bound to FPRL1 and promoted an increase in intracellular Ca2+. concentration ([Ca2+](i)), and neither interacted with nor activated FPR, demonstrating that MCT-2 is a specific agonist for FPRL1. Moreover, MCT-2 induced not only [Ca2+](i); increase and phosphorylation of extracellular signal-regulated protein kinases 1 and 2, but also B-hexosaminidase release in neutrophilic/granulocytic cells differentiated from HL-60 cells. Such signaling events were diminished by pretreatment with pertussis toxin, indicating that MCT-2-promoted neutrophilic function is a consequence of G(i)- or G(o)-type G protein-dependent intracellular signaling events via FPRL1 activation. These findings suggest that MCT-2, a cryptide derived from mitochondrial cytochrome b, is a specific endogenous agonist for FPRL1 which is proposed to play key roles in inflammatory responses but whose physiological agonists are equivocal. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:482 / 487
页数:6
相关论文
共 50 条
  • [41] Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages
    Yang, D
    Chen, Q
    Le, YY
    Wang, JM
    Oppenheim, JJ
    JOURNAL OF IMMUNOLOGY, 2001, 166 (06): : 4092 - 4098
  • [42] Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor α production
    Schepetkin, Igor A.
    Kirpotina, Liliya N.
    Tian, Jun
    Khlebnikov, Andrei I.
    Ye, Richard D.
    Quinn, Mark T.
    MOLECULAR PHARMACOLOGY, 2008, 74 (02) : 392 - 402
  • [43] N-formyl peptide receptor-like 1 of the neutrophils in the AA-amyloidosis tissues is less stained
    Ohara, E.
    Kumon, Y.
    Sugiura, T.
    XIth International Symposium on Amyloidosis, 2008, : 84 - 87
  • [44] Serum amyloid a induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes
    Lee, Ha Young
    Kim, Mi-Kyoung
    Park, Kyoung Sun
    Shin, Eun Ha
    Jo, Seong Ho
    Kim, Sang Doo
    Jo, Eun Jin
    Lee, Youl-Nam
    Lee, Chuhee
    Baek, Suk-Hwan
    Bae, Yoe-Sik
    MOLECULAR PHARMACOLOGY, 2006, 70 (01) : 241 - 248
  • [45] A truncated form of CKβ8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor
    Elagoz, A
    Henderson, D
    Babu, PS
    Salter, S
    Grahames, C
    Bowers, L
    Roy, MO
    Laplante, P
    Grazzini, E
    Ahmad, S
    Lembo, PMC
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (01) : 37 - 46
  • [46] VEGFR2 transactivation by formyl-peptide receptor 1 requires NADPH oxidase-dependent superoxide generation
    Castaldo, M.
    Cattaneo, F.
    Parisi, M.
    Esposito, G.
    Ammendola, R.
    FEBS OPEN BIO, 2018, 8 : 383 - 383
  • [47] The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1
    Svensson, L
    Dahlgren, C
    Wennerås, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (04) : 810 - 818
  • [48] Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
    Dufton, Neil
    Hannon, Robert
    Brancaleone, Vincenzo
    Dalli, Jesmond
    Patel, Hetal B.
    Gray, Mohini
    D'Acquisto, Fulvio
    Buckingham, Julia C.
    Perretti, Mauro
    Flower, Roderick J.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (05): : 2611 - 2619
  • [49] N-formyl peptide receptor-like 1 of the polymorphonuclear cells in the AA-amyloid tissue is less stained
    Ohara, E.
    Kumon, Y.
    Sugiura, T.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 : 49 - 49
  • [50] Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1 (vol 72, pg 976, 2007)
    Zhou, C.
    Zhang, S.
    Nanamori, M.
    Zhang, Y.
    Liu, Q.
    Li, N.
    Sun, M.
    Tian, J.
    Ye, P. P.
    Cheng, N.
    Ye, R. D.
    Wang, M. W.
    MOLECULAR PHARMACOLOGY, 2007, 72 (05) : 1391 - 1391